The levels of serum TG, serum cholesterol, liver TG and liver cholesterol were significantly lower in H19-overexpressing mice (Fig. 1g, supplementary Fig. 1D-F), indicating improvements in dyslipidemia and fatty liver symptoms. Here, H19 is linked to metabolic syndrome.